https://arxiv.org/api/chogrNhvD1a7tu+BoEm/oX/4y5A 2026-06-18T11:18:24Z 1596 270 15 http://arxiv.org/abs/2406.02623v2 The Vertebrate Breed Ontology: Towards Effective Breed Data Standardization 2025-01-24T18:22:38Z Background: Limited universally-adopted data standards in veterinary medicine hinder data interoperability and therefore integration and comparison; this ultimately impedes the application of existing information-based tools to support advancement in diagnostics, treatments, and precision medicine. Objectives: A single, coherent, logic-based standard for documenting breed names in health, production, and research-related records will improve data use capabilities in veterinary and comparative medicine. Methods: The Vertebrate Breed Ontology (VBO) was created from breed names and related information compiled from the Food and Agriculture Organization of the United Nations, breed registries, communities, and experts, using manual and computational approaches. Each breed is represented by a VBO term that includes breed information and provenance as metadata. VBO terms are classified using description logic to allow computational applications and Artificial Intelligence-readiness. Results: VBO is an open, community-driven ontology representing over 19,500 livestock and companion animal breed concepts covering 49 species. Breeds are classified based on community and expert conventions (e.g., cattle breed) and supported by relations to the breed's genus and species indicated by National Center for Biotechnology Information (NCBI) Taxonomy terms. Relationships between VBO terms (e.g., relating breeds to their foundation stock) provide additional context to support advanced data analytics. VBO term metadata includes synonyms, breed identifiers/codes, and attributed cross-references to other databases. Conclusion and clinical importance: The adoption of VBO as a source of standard breed names in databases and veterinary electronic health records can enhance veterinary data interoperability and computability. 2024-06-03T20:06:41Z Kathleen R. Mullen Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA Imke Tammen Sydney School of Veterinary Science, The University of Sydney, Sydney, NSW, Australia Nicolas A. Matentzoglu Semanticly Ltd, Athens, Greece Marius Mather Sydney Informatics Hub, The University of Sydney, Sydney, NSW, Australia James P. Balhoff Renaissance Computing Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA Elizabeth Esdaile Veterinary Genetics Laboratory, School of Veterinary Medicine, University of California, Davis, CA, USA. Current affiliation is Department of Clinical Sciences, Colorado State University, Fort Collins, CO, USA Gregoire Leroy Animal Production and Health Division, Food and Agriculture Organization of the United Nations, Rome, Italy Carissa A. Park Department of Animal Science, Iowa State University, Ames, IA, USA Halie M. Rando Department of Computer Science, Smith College, Northampton, MA, USA Nadia T. Saklou Department of Clinical Sciences, Colorado State University, Fort Collins, CO, USA Tracy L. Webb Department of Clinical Sciences, Colorado State University, Fort Collins, CO, USA Nicole A. Vasilevsky Data Collaboration Center, Critical Path Institute, Tucson, AZ, USA Christopher J. Mungall Lawrence Berkeley National Laboratory, Berkeley, CA, USA Melissa A. Haendel Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA Frank W. Nicholas Sydney School of Veterinary Science, The University of Sydney, Sydney, NSW, Australia Sabrina Toro Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA 10.1111/jvim.70133 http://arxiv.org/abs/2501.16982v1 Human Genome Book: Words, Sentences and Paragraphs 2025-01-23T04:39:24Z Since the completion of the human genome sequencing project in 2001, significant progress has been made in areas such as gene regulation editing and protein structure prediction. However, given the vast amount of genomic data, the segments that can be fully annotated and understood remain relatively limited. If we consider the genome as a book, constructing its equivalents of words, sentences, and paragraphs has been a long-standing and popular research direction. Recently, studies on transfer learning in large language models have provided a novel approach to this challenge.Multilingual transfer ability, which assesses how well models fine-tuned on a source language can be applied to other languages, has been extensively studied in multilingual pre-trained models. Similarly, the transfer of natural language capabilities to "DNA language" has also been validated. Building upon these findings, we first trained a foundational model capable of transferring linguistic capabilities from English to DNA sequences. Using this model, we constructed a vocabulary of DNA words and mapped DNA words to their English equivalents.Subsequently, we fine-tuned this model using English datasets for paragraphing and sentence segmentation to develop models capable of segmenting DNA sequences into sentences and paragraphs. Leveraging these models, we processed the GRCh38.p14 human genome by segmenting, tokenizing, and organizing it into a "book" comprised of genomic "words," "sentences," and "paragraphs." Additionally, based on the DNA-to-English vocabulary mapping, we created an "English version" of the genomic book. This study offers a novel perspective for understanding the genome and provides exciting possibilities for developing innovative tools for DNA search, generation, and analysis. 2025-01-23T04:39:24Z 17 pages,5 figures Wang Liang http://arxiv.org/abs/2501.13135v1 Applications and Challenges of AI and Microscopy in Life Science Research: A Review 2025-01-22T08:32:36Z The complexity of human biology and its intricate systems holds immense potential for advancing human health, disease treatment, and scientific discovery. However, traditional manual methods for studying biological interactions are often constrained by the sheer volume and complexity of biological data. Artificial Intelligence (AI), with its proven ability to analyze vast datasets, offers a transformative approach to addressing these challenges. This paper explores the intersection of AI and microscopy in life sciences, emphasizing their potential applications and associated challenges. We provide a detailed review of how various biological systems can benefit from AI, highlighting the types of data and labeling requirements unique to this domain. Particular attention is given to microscopy data, exploring the specific AI techniques required to process and interpret this information. By addressing challenges such as data heterogeneity and annotation scarcity, we outline potential solutions and emerging trends in the field. Written primarily from an AI perspective, this paper aims to serve as a valuable resource for researchers working at the intersection of AI, microscopy, and biology. It summarizes current advancements, key insights, and open problems, fostering an understanding that encourages interdisciplinary collaborations. By offering a comprehensive yet concise synthesis of the field, this paper aspires to catalyze innovation, promote cross-disciplinary engagement, and accelerate the adoption of AI in life science research. 2025-01-22T08:32:36Z Himanshu Buckchash Gyanendra Kumar Verma Dilip K. Prasad http://arxiv.org/abs/2501.11037v1 Toxicological Evaluation of Phytochemicals and Heavy Metals in Ficus exasperata Vahl (Sandpaper) Leaves obtained in Birnin Kebbi, Nigeria 2025-01-19T13:09:12Z Objective: Ficus exasperata Vahl (Sandpaper tree) is extensively used in Nigeria to treat diseases, but a dearth of documentation about its toxicity exists. This information is crucial because pollutants can contaminate medicinal plants. This study determined the heavy metal and phytochemical content of methanolic leaf extract of F exasperata obtained in Birnin Kebbi, Nigeria. Material and Methods: The lethality of the plant was also assessed using 70 wild shrimps divided equally into seven groups. Group 1 (negative control), groups 2 and 3 (positive controls) were exposed to 500 and 1000ppm of formaldehyde, respectively; and groups 4-7 were exposed to 1000, 2000, 4000, and 8000ppm of extracts, respectively, for 96 hours. Results: The phytochemistry revealed high levels of flavonoids and saponins and moderate levels of tannins and phenols. The heavy metal analysis revealed non-tolerable levels of cadmium, copper, and lead, while zinc was within the tolerable limit. The negative control recorded 10% mortality, 1000 and 2000 ppm (20% each), 4000ppm (70%), and 8000 ppm (100%). Conclusion: These results inferred safe doses of the plant's extract in low and medium concentrations but toxic and fatal at high doses over a period of time. Consumers are advised to seek an expert's guidance before using it. 2025-01-19T13:09:12Z 7 pages Tajudeen O. Yahaya Titilola F. Salisu Israel O. Obaroh Muyiwa A. Adelabu Abdulrazaq Izuafa Jamilu B. Danjuma Hamdalat Sheu Ibrahim B. Abdulgafar http://arxiv.org/abs/2501.09473v1 An Asymptotic Analysis of Bivalent Monoclonal Antibody-Antigen Binding 2025-01-16T11:23:55Z Ligand-receptor interactions are fundamental to many biological processes. For example in antibody-based immunotherapies, the dynamics of an antibody binding with its target antigen directly influence the potency and efficacy of monoclonal antibody (mAb) therapies. In this paper, we present an asymptotic analysis of an ordinary differential equation (ODE) model of bivalent antibody-antigen binding in the context of mAb cancer therapies, highlighting the added complexity associated with bivalency of the antibody. To understand what drives the complex temporal dynamics of bivalent antibody-antigen binding, we construct asymptotic approximations to the model's solutions at different timescales and antibody concentrations that are in good agreement with numerical simulations of the full model. We show how the dynamics differ between two scenarios; a region where unbound antigens are abundant, and one where the number of unbound antigens is small such that the dominant balance within the model equations changes. Of particular importance to the potency and efficacy of mAb treatments are the values of quantities such as antigen occupancy and bound antibody number. We use the results of our asymptotic analysis to approximate the long-time values of these quantities that could be combined with experimental data to facilitate parameter estimation. 2025-01-16T11:23:55Z Luke A Heirene Helen M Byrne James W T Yates Eamonn A Gaffney http://arxiv.org/abs/2501.08567v2 A new perspective on brain stimulation interventions: Optimal stochastic tracking control of brain network dynamics 2025-01-16T08:52:54Z Network control theory (NCT) has recently been utilized in neuroscience to facilitate our understanding of brain stimulation effects. A particularly useful branch of NCT is optimal control, which focuses on applying theoretical and computational principles of control theory to design optimal strategies to achieve specific goals in neural processes. However, most existing research focuses on optimally controlling brain network dynamics from the original state to a target state at a specific time point. In this paper, we present the first investigation of introducing optimal stochastic tracking control strategy to synchronize the dynamics of the brain network to a target dynamics rather than to a target state at a specific time point. We utilized fMRI data from healthy groups, and cases of stroke and post-stroke aphasia. For all participants, we utilized a gradient descent optimization method to estimate the parameters for the brain network dynamic system. We then utilized optimal stochastic tracking control techniques to drive original unhealthy dynamics by controlling a certain number of nodes to synchronize with target healthy dynamics. Results show that the energy associated with optimal stochastic tracking control is negatively correlated with the intrinsic average controllability of the brain network system, while the energy of the optimal state approaching control is significantly related to the target state value. For a 100-dimensional brain network system, controlling the five nodes with the lowest tracking energy can achieve relatively acceptable dynamics control effects. Our results suggest that stochastic tracking control is more aligned with the objective of brain stimulation interventions, and is closely related to the intrinsic characteristics of the brain network system, potentially representing a new direction for future brain network optimal control research. 2025-01-15T04:19:52Z Supplementary materials can be found at: https://zjueducn-my.sharepoint.com/:b:/g/personal/dongkl_zju_edu_cn/EbG817wduDFIgqqS3zt2d4gB0OZXM9wt-v18Xr41zXS1Fg?e=XOGNwG Kangli Dong Siya Chen Ying Dan Lu Zhang Xinyi Li Wei Liang Yue Zhao Yu Sun http://arxiv.org/abs/2407.15908v2 The Genomic Code: The genome instantiates a generative model of the organism 2025-01-16T08:26:03Z How does the genome encode the form of the organism? What is the nature of this genomic code? Inspired by recent work in machine learning and neuroscience, we propose that the genome encodes a generative model of the organism. In this scheme, by analogy with variational autoencoders, the genome comprises a connectionist network, embodying a compressed space of latent variables, with weights that get encoded by the learning algorithm of evolution and decoded through the processes of development. The generative model analogy accounts for the complex, distributed genetic architecture of most traits and the emergent robustness and evolvability of developmental processes, while also offering a conception that lends itself to formalisation. 2024-07-22T16:41:25Z 33 pages, 4 figures Kevin J. Mitchell Nick Cheney http://arxiv.org/abs/2501.08650v1 Être mineur non accompagné à Paris: exploration des facteurs déterminants des besoins en santé physique et mentale par une étude qualitative 2025-01-15T08:25:09Z In France, government protection of unaccompanied minors (UMs) depends upon the recognition of their minority status and often result in a rejection. A significant proportion of UMs therefore find themselves unprotected. This qualitative study explores the contextual and individual factors that shape the physical and mental health needs of unprotected UMs in Paris. Interviews were conducted with UMs (n=12) and those working with them (n=36). A deductive-inductive thematic analysis was carried out. The study contributes to the analysis of the health determinants of unprotected UMs. It shows that institutional barriers limit the scope for action by civil society in the palliative care they receive. The consequence for them is living in conditions of instability and precariousness, with very little prospects for the future, which has a negative impact on their physical and mental health. 2025-01-15T08:25:09Z in French language Revue Européenne des Migrations Internationales, A paraître, 42-2&3 (2026) Lignon Lignon MDM Juan Diego Poveda MDM Stéphanie Wakap Nguengang MDM Lara Gautier http://arxiv.org/abs/2404.11403v4 Six decades of the FitzHugh-Nagumo model: A guide through its spatio-temporal dynamics and influence across disciplines 2025-01-06T19:25:03Z The FitzHugh-Nagumo equation, originally conceived in neuroscience during the 1960s, became a key model providing a simplified view of excitable neuron cell behavior. Its applicability, however, extends beyond neuroscience into fields like cardiac physiology, cell division, population dynamics, electronics, and other natural phenomena. In this review spanning six decades of research, we discuss the diverse spatio-temporal dynamical behaviors described by the FitzHugh-Nagumo equation. These include dynamics like bistability, oscillations, and excitability, but it also addresses more complex phenomena such as traveling waves and extended patterns in coupled systems. The review serves as a guide for modelers aiming to utilize the strengths of the FitzHugh-Nagumo model to capture generic dynamical behavior. It not only catalogs known dynamical states and bifurcations, but also extends previous studies by providing stability and bifurcation analyses for coupled spatial systems. 2024-04-17T14:08:17Z 39 pages, 18 figures Physics Reports, vol. 1096, pp. 1-39, 2024 Daniel Cebrián-Lacasa Pedro Parra-Rivas Daniel Ruiz-Reynés Lendert Gelens 10.1016/j.physrep.2024.09.014 http://arxiv.org/abs/2501.01043v1 Higher serum 25(OH)D concentration is associated with lower risk of metabolic syndrome among Aboriginal and Torres Strait Islander peoples in Australia 2025-01-02T04:02:50Z Although previous observational studies have shown associations between serum 25-hydroxyvitamin D (25(OH)D) concentration and metabolic syndrome, this association has not yet been investigated among Aboriginal and Torres Strait Islander peoples. We aimed to investigate the association between serum 25(OH)D concentration and metabolic syndrome and its risk factors in this population group. We used cross-sectional data from the 2012-2013 Australian Aboriginal and Torres Strait Islander Health Survey. Metabolic syndrome is defined as having 3 or more risk factors: elevated waist circumference, elevated triglycerides, low high-density lipoprotein (HDL) cholesterol, elevated blood pressure, or elevated fasting blood glucose. We used binomial logistic regression to test associations between serum 25(OH)D concentration and metabolic syndrome, and multiple linear regression to test associations between serum 25(OH)D concentration and each risk factor. We included the following covariates: age, sex, smoking status, education level, socio-economic status, remoteness of location, season, and body mass index (BMI). After adjusting for covariates, we found that each 10 nmol/L increase in serum 25(OH)D concentration was statistically significantly associated with a 16% lower risk of metabolic syndrome (odds ratio: 0.84, 95% confidence interval: 0.76, 0.92) and a 2.1 cm (95% confidence interval: 1.65, 2.57) lower waist circumference (BMI was not included in the model for waist circumference). We found small inverse associations between serum 25(OH)D concentration and all other risk factors except systolic blood pressure. Given that higher serum 25(OH)D concentration may confer metabolic health benefits, promoting vitamin D sufficiency may be beneficial for this population. 2025-01-02T04:02:50Z Belinda Neo Curtin Medical School, Curtin University, Bentley, Western Australia, Australia Dale Tilbrook Maalingup Aboriginal Gallery, Caversham, Western Australia, Australia Noel Nannup The Kids Research Institute Australia, The University of Western Australia, Nedlands, Western Australia, Australia John Jacky The Kids Research Institute Australia, The University of Western Australia, Nedlands, Western Australia, Australia Carol Michie The Kids Research Institute Australia, The University of Western Australia, Nedlands, Western Australia, Australia Cindy Prior The Kids Research Institute Australia, The University of Western Australia, Nedlands, Western Australia, Australia Eleanor Dunlop Curtin School of Population Health, Curtin University, Bentley, Western Australia, Australia Institute for Physical Activity and Nutrition Brad Farrant The Kids Research Institute Australia, The University of Western Australia, Nedlands, Western Australia, Australia Won Sun Chen Curtin Medical School, Curtin University, Bentley, Western Australia, Australia Carrington C. J. Shepherd Curtin Medical School, Curtin University, Bentley, Western Australia, Australia The Kids Research Institute Australia, The University of Western Australia, Nedlands, Western Australia, Australia Ngangk Yira Institute, Murdoch University, Murdoch, Western Australia, Australia Lucinda J. Black Curtin School of Population Health, Curtin University, Bentley, Western Australia, Australia Institute for Physical Activity and Nutrition . http://arxiv.org/abs/2412.20616v1 Hilbert Curve Based Molecular Sequence Analysis 2024-12-29T23:26:43Z Accurate molecular sequence analysis is a key task in the field of bioinformatics. To apply molecular sequence classification algorithms, we first need to generate the appropriate representations of the sequences. Traditional numeric sequence representation techniques are mostly based on sequence alignment that faces limitations in the form of lack of accuracy. Although several alignment-free techniques have also been introduced, their tabular data form results in low performance when used with Deep Learning (DL) models compared to the competitive performance observed in the case of image-based data. To find a solution to this problem and to make Deep Learning (DL) models function to their maximum potential while capturing the important spatial information in the sequence data, we propose a universal Hibert curve-based Chaos Game Representation (CGR) method. This method is a transformative function that involves a novel Alphabetic index mapping technique used in constructing Hilbert curve-based image representation from molecular sequences. Our method can be globally applied to any type of molecular sequence data. The Hilbert curve-based image representations can be used as input to sophisticated vision DL models for sequence classification. The proposed method shows promising results as it outperforms current state-of-the-art methods by achieving a high accuracy of $94.5$\% and an F1 score of $93.9\%$ when tested with the CNN model on the lung cancer dataset. This approach opens up a new horizon for exploring molecular sequence analysis using image classification methods. 2024-12-29T23:26:43Z Sarwan Ali Tamkanat E Ali Imdad Ullah Khan Murray Patterson http://arxiv.org/abs/2412.18030v1 Moving boundaries: An appreciation of John Hopfield 2024-12-23T22:50:57Z The 2024 Nobel Prize in Physics was awarded to John Hopfield and Geoffrey Hinton, "for foundational discoveries and inventions that enable machine learning with artificial neural networks." As noted by the Nobel committee, their work moved the boundaries of physics. This is a brief reflection on Hopfield's work, its implications for the emergence of biological physics as a part of physics, the path from his early papers to the modern revolution in artificial intelligence, and prospects for the future. 2024-12-23T22:50:57Z William Bialek http://arxiv.org/abs/2412.17005v1 Investigation of phytochemicals, spectral properties, anticancer, antidiabetic, and antimicrobial activities of chosen Ayurvedic remedies 2024-12-22T12:56:06Z This study examines the phytochemical characteristics of Ayurvedic products. An analysis was performed on Kottakkal Ayurveda Triphala (T), Kottakkal Ayurveda Hinguvachadi Churnam (H), and Kottakkal Ayurveda Jirakadyarishtam (J) using GC-MS and LC-MS techniques to determine their bioactive constituents, while also assessing their antimicrobial, docking, anticancer, and anti-diabetic activities. The GC-MS analysis identified 30, 45, and 8 chemical components in Kottakkal Ayurveda Triphala (T), Kottakkal Ayurveda Hinguvachadi Churnam (H), and Kottakkal Ayurveda Jirakadyarishtam (J), respectively. The LC-MS analysis produced 15, 20, and 16 peaks for Kottakkal Ayurveda Triphala (T), Kottakkal Ayurveda Hinguvachadi Churnam (H), and Kottakkal Ayurveda Jirakadyarishtam (J), with m/z values of 982, 981, 972, and 933; 987, 985, 974, and 945; and 969, 965, 951, and 941, respectively, confirming their precision. Moreover, characterization of the Ayurvedic products was carried out using FT-IR, UV-vis, and 1H-NMR spectroscopy to identify significant functional groups and chemical substances. Kottakkal Ayurveda Triphala (T) was evaluated for antibacterial activity against Gram-positive bacteria (Streptococcus pneumoniae and Staphylococcus aureus) along with Gram-negative bacteria (Escherichia coli and Klebsiella pneumoniae), yielding a P value of 0.0650 (P < 0.0001). Both Kottakkal Ayurveda Hinguvachadi Churnam (H) and Kottakkal Ayurveda Jirakadyarishtam (J) were subjected to analysis for their effectiveness against Aspergillus niger and Aspergillus fumigatus, also revealing a P value within the acceptable range of 0.0650 (P < 0.0001). The anti-diabetic properties of Kottakkal Ayurveda Triphala (T) were assessed using the α-glucosidase inhibitory method, which exhibited a significant inhibitory effect on α-glucosidase, resulting in an average P value of 0.001 (P < 0.0001). 2024-12-22T12:56:06Z for associated mpeg file, see http://myhost.domain/file.mpg J.Hasty Results 1 (2008) 1-9; Erratum: J.Hasty Results 2 (2008) 1-2 T. H. Mohamed Ahadu Shareef Irfan Navabshan M Mohamed Divan Masood T. Eswara Yuvaraj A. Sherif 10.1016/S0550-3213(01)00405-9 http://arxiv.org/abs/2412.16705v1 Exploring the Multifractal Behavior of the Human Genome T2T-CHM13v2.0: Graphical Representations and Cytogenetics 2024-12-21T17:06:46Z In this work, we applied the Chaos Game Representation (CGR) to the complete human genomic sequence T2T-CHM13v2.0, analyzing the entire chromosome assembly and each chromosome separately, including mitochondrial DNA. Multifractal spectra were determined using two types of box-counting coverage, revealing slight variations across most chromosomes. While the geometric support remained consistent, distinct distributions were observed for each chromosome. Chromosomes 9 and Y exhibited the greatest differences in singularity (Hölder exponent), with minor variations in their fractal support. The CGR distributions generally demonstrated an approximate separation between coding and non-coding sections, as well as CpG or GpC islands. A base-by-base analysis of the fractal support of the CGR uncovered characteristic structural bands in chromosome sequences, which align with patterns identified in cytogenetic studies. Using the complete assembly as a reference, we compared two alternative representations: the Binary Genomic Representation (RGB) and the Markov Chain (MC) representation. Both methods tended toward the same fractal support but displayed differing distributions based on the assigned length parameter. Multifractal analysis highlighted quantitative differences between these representations: RGB aligned more closely with high-frequency components, while MC showed better correspondence with low frequencies. The optimal fit was achieved using MC for twelve-base chains, yielding an average percentage error of 2% relative to the full genomic assembly. 2024-12-21T17:06:46Z Yulián A. Alvarez-Ballesteros Mario A. Quiroz-Juarez José L. Del-Rio-Correa Adrian M. Escobar-Ruiz http://arxiv.org/abs/2412.14338v1 GREGoR: Accelerating Genomics for Rare Diseases 2024-12-18T21:11:13Z Rare diseases are collectively common, affecting approximately one in twenty individuals worldwide. In recent years, rapid progress has been made in rare disease diagnostics due to advances in DNA sequencing, development of new computational and experimental approaches to prioritize genes and genetic variants, and increased global exchange of clinical and genetic data. However, more than half of individuals suspected to have a rare disease lack a genetic diagnosis. The Genomics Research to Elucidate the Genetics of Rare Diseases (GREGoR) Consortium was initiated to study thousands of challenging rare disease cases and families and apply, standardize, and evaluate emerging genomics technologies and analytics to accelerate their adoption in clinical practice. Further, all data generated, currently representing ~7500 individuals from ~3000 families, is rapidly made available to researchers worldwide via the Genomic Data Science Analysis, Visualization, and Informatics Lab-space (AnVIL) to catalyze global efforts to develop approaches for genetic diagnoses in rare diseases (https://gregorconsortium.org/data). The majority of these families have undergone prior clinical genetic testing but remained unsolved, with most being exome-negative. Here, we describe the collaborative research framework, datasets, and discoveries comprising GREGoR that will provide foundational resources and substrates for the future of rare disease genomics. 2024-12-18T21:11:13Z Moez Dawood GREGoR Ben Heavner GREGoR Marsha M. Wheeler GREGoR Rachel A. Ungar GREGoR Jonathan LoTempio GREGoR Laurens Wiel GREGoR Seth Berger GREGoR Jonathan A. Bernstein GREGoR Jessica X. Chong GREGoR Emmanuèle C. Délot GREGoR Evan E. Eichler GREGoR Richard A. Gibbs GREGoR James R. Lupski GREGoR Ali Shojaie GREGoR Michael E. Talkowski GREGoR Alex H. Wagner GREGoR Chia-Lin Wei GREGoR Christopher Wellington GREGoR Matthew T. Wheeler GREGoR GREGoR Partner Members GREGoR Claudia M. B. Carvalho GREGoR Casey A. Gifford GREGoR Susanne May GREGoR Danny E. Miller GREGoR Heidi L. Rehm GREGoR Fritz J. Sedlazeck GREGoR Eric Vilain GREGoR Anne O'Donnell-Luria GREGoR Jennifer E. Posey GREGoR Lisa H. Chadwick GREGoR Michael J. Bamshad GREGoR Stephen B. Montgomery GREGoR Genomics Research to Elucidate the Genetics of Rare Diseases GREGoR Consortium